These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29383815)

  • 1. Viral safety of coagulation factor concentrates: memoirs from an insider.
    Mannucci PM
    J Thromb Haemost; 2018 Apr; 16(4):630-633. PubMed ID: 29383815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV and hemophilia.
    Aledort LM; Evatt BL; Lusher JM; Brownstein AP
    J Thromb Haemost; 2007 Mar; 5(3):607-10. PubMed ID: 17319907
    [No Abstract]   [Full Text] [Related]  

  • 3. Haemophilia, human immunodeficiency virus and human immunodeficiency virus pathogenesis.
    Lederman MM
    Thromb Haemost; 2010 Nov; 104(5):911-4. PubMed ID: 20694275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying the source of infection for HIV-infected hemophiliacs in the U.K. from 1979 to 1984.
    Jewell NP
    Stat Med; 2009 May; 28(10):1464-72. PubMed ID: 19235711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AIDS, hepatitis and hemophilia in the 1980s: memoirs from an insider.
    Mannucci PM
    J Thromb Haemost; 2003 Oct; 1(10):2065-9. PubMed ID: 14521583
    [No Abstract]   [Full Text] [Related]  

  • 6. Living donor liver transplantation for hemophilia with special reference to the management of perioperative clotting factor replacement.
    Togashi J; Akamatsu N; Tanaka T; Sugawara Y; Tsukada K; Kaneko J; Arita J; Sakamoto Y; Hasegawa K; Kokudo N
    Liver Transpl; 2016 Mar; 22(3):366-70. PubMed ID: 26390184
    [No Abstract]   [Full Text] [Related]  

  • 7. Infection with hepatitis GB virus among Japanese hemophiliacs.
    Nishiyama Y; Nakashima H; Hino K; Mori K; Ishikawa M; Okamoto H
    Transfusion; 1996 Jul; 36(7):669. PubMed ID: 8701464
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the risk of hepatitis from clotting factor concentrates.
    Fricke WA
    Prog Clin Biol Res; 1990; 324():161-6. PubMed ID: 2408051
    [No Abstract]   [Full Text] [Related]  

  • 9. Reconstruction of the historic time course of blood-borne virus contamination of clotting factor concentrates, 1974-1992.
    McClure CP; Kean K; Reid K; Mayne R; Fu MX; Rajendra P; Gates S; Breuer J; Harvala H; Golubchik T; Tarr AW; Irving WL; Makris M; Simmonds P
    J Med Virol; 2024 Jul; 96(7):e29774. PubMed ID: 38953434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral safety of clotting factor concentrates.
    Fricke WA; Lamb MA
    Semin Thromb Hemost; 1993; 19(1):54-61. PubMed ID: 8456324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. History of prophylaxis.
    Berntorp E
    Haemophilia; 2013 Mar; 19(2):163-5. PubMed ID: 23419107
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemophilia: an amazing 35-year journey from the depths of HIV to the threshold of cure.
    White GC
    Trans Am Clin Climatol Assoc; 2010; 121():61-73; discussion 74-5. PubMed ID: 20697550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the transmission of hepatitis by clotting factor concentrates.
    Tabor E
    Scand J Haematol Suppl; 1984; 40():303-8. PubMed ID: 6433456
    [No Abstract]   [Full Text] [Related]  

  • 14. Transfusion-transmitted disease.
    Lee CA
    Baillieres Clin Haematol; 1996 Jun; 9(2):369-94. PubMed ID: 8800511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choice of replacement therapy for hemophilia: recombinant products only?
    Mannucci PM; Giangrande PL
    Hematol J; 2000; 1(2):72-6. PubMed ID: 11920173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral safety of plasma-derived factor VIII and IX concentrates.
    Ludlam CA
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S19-23. PubMed ID: 9351532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porcine factor VIII.
    Giangrande PL
    Haemophilia; 2012 May; 18(3):305-9. PubMed ID: 22531020
    [No Abstract]   [Full Text] [Related]  

  • 18. Human immunodeficiency virus infection due to clotting factor concentrates: results of the Seroconversion Surveillance Project.
    Fricke W; Augustyniak L; Lawrence D; Brownstein A; Kramer A; Evatt B
    Transfusion; 1992 Oct; 32(8):707-9. PubMed ID: 1412676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No hepatitis after treatment with a modified factor IX concentrate in previously untreated hemophiliacs.
    Mannucci PM; Morfini M; Gatti L; Rafanelli D; Colombo M; Geroldi D; Einarsson M; Zanetti AR
    Ann Intern Med; 1985 Aug; 103(2):226-7. PubMed ID: 4014905
    [No Abstract]   [Full Text] [Related]  

  • 20. Negative and positive developments during the last 25 years.
    Alonso Gómez J
    Haemostasis; 1992; 22(5):305-8. PubMed ID: 1478542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.